外泌体对乳腺癌诊疗一体化影响的研究进展

doi:10.11904/j.issn.1002-3070.2022.02.014

Abstract

Abstract: Breast cancer has overtaken lung cancer as the world′s leading cancer,according to the latest global cancer statistics for 2020.Thus,how to the sensitivity of diagnosis and treatment of breast cancer of strengthening is vital for the prognosis of breast cancer,and outside body secretion,and because of its with invasion and metastasis of breast cancer cells in the process of occurrence and development,drug carrier transport and the body resistance,cytokine secretion expression and is closely related to immune response and so on,so integration and prognosis of breast cancer diagnosis and treatment has a great influence.This article reviews the diagnosis of exosome and its effect on the treatment and prognosis of breast cancer.

Key words: Exosoms, Breast cancer, In vivo tracing, Targeted therapy

CLC Number:

R737.9

HOU Jianxun, WANG Hongbin. Research progress on the influence of exosomes in the integration of breast cancer diagnosis and treatment[J]. Journal of Practical Oncology, 2022, 36(2): 178-182.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2022.02.014

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2022/V36/I2/178

References

1 Jacopo M.Exosomes and ectosomes in intercellular communication[J].Curr Biol,2018,28(8):435-444.
2 Thery C,Amigorena S,Raposo G,et al.Isolation and characterization of exosomes from cell culture supernatants and biological fluids[J].Curr Protoc Cell Biol,2006,3(1):1-29.
3 Ludwig N,Razzo BM,Yerneni SS,et al.Optimization of cell culture conditions for exosome isolation using mini-size exclusion chromatography(mini-SEC)[J].Exp Cell Res,2019,378(2):149-157.
4 Li P,Kaslan M,Lee SH,et al.Progress in exosome isolation techniques[J].Theranostics,2017,7(3):789-804.
5 刘梦瑶,姜立新.外泌体活体示踪的分子影像学研究进展[J].医学研究杂志,2021,50(1):145-148.
6 Gao X,Li S,Ding F,et al.Rapid detection of exosomal MicroRNAs using virus-mimicking fusogenic vesicles[J].Angew Chem Int Ed Engl,2019,58(26):8719-8723.
7 许乘凤,杨振林,花义同,等.外泌体在体外对乳腺癌细胞耐药信息传递的作用[J].西安交通大学学报(医学版),2017,38(2):193-198.
8 Valadi H,Ekström K,Bossios A,et al.Exosome-mediated transfer of mRNAs and microRNAs is aenovel mechanism of genetic exchange between cells[J].Nat Cell Biol,2007,9(6):654-659.
9 Jia L,Yang A.Noncoding RNAs in therapeutic resistance of cancer[J].Adv Exp Med Biol,2016(927):265-295.
10 Liu J,Zhu S,Tang W,et al.Correction to:Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p[J].Cancer Cell Int,2021,21(1):673.
11 Keklikoglou I,Cianciaruso C,GüçE,et al.Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models[J].Nat Cell Biol,2019,21(2):190-202.
12 Gobbo J,Marcion G,Cordonnier M,et al.Restoring anticancer immune response by targeting Tumor-Derived Exosomes with a HSP70 peptide aptamer[J].J Natl Cancer Inst,2015,108(3):10.
13 Hoshino A,Costa-Silva B,Shen TL,et al.Tumour exosome integrins determine organotropic metastasis[J].Nature,2015,527(7578):329-335.
14 Baroni S,Romero-Cordoba S,Plantamura I,et al.Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts[J].Cell Death Dis,2016,7(7):e2312.
15 Zhou W,Fong MY,Min Y,et al.Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis[J].Cancer Cell,2014,25(4):501-515.
16 Le MT,Hamar P,Guo C,et al.miR-200-containing extracellular vesicles promote breast cancer cell metastasis[J].J Clin Invest,2014,124(12):5109-5128.
17 Ragusa M,Statello L,Maugeri M,et al.Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment:biomolecular,genetic and translational implications[J].Oncoscience,2014,1(2):132-157.
18 Jena BC,Mandal M.The emerging roles of exosomes in anti-cancer drug resistance and tumor progression:an insight towards tumor-microenvironment interaction[J].Biochim Biophys Acta Rev Cancer,2021,1875(1):188488.
19 Logozzi M,Mizzoni D,Angelini DF,et al.Microenvironmental pH and exosome levels interplay in human cancer cell Lines of different histotypes[J].Cancers(Basel),2018,10(10):370.
20 陈勇.乳腺癌细胞外泌体诱导骨髓细胞分化为髓系来源抑制性细胞的作用及其机理[D].南昌:南昌大学,2019.
21 Koh E,Lee EJ,Nam GH,et al.Exosome-SIRPα,a CD47 blockade increases cancer cell phagocytosis[J].Biomaterials,2017,121:121-129.
22 Asgharzadeh MR,Barar J,Pourseif MM,et al.Molecular machineries of pH dysregulation in tumor microenvironment:potential targets for cancer therapy[J].Bioimpacts,2017,7(2):115-133.
23 Bellone M,Calcinotto A,Filipazzi P,et al.The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors[J].Oncoimmunology,2013,2(1):e22058.
24 王爱红,赵菊梅,王明全.PD-1、CTLA-4和MMP9在伴或不伴淋巴结转移乳腺癌患者外泌体中的表达[J].现代免疫学,2019,39(2):110-114.
25 Wang S,Su X,Xu M,et al.Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway[J].Stem Cell Res Ther,2019,10(1):117.
26 Zheng M,Huang M,Ma X,et al.Harnessing exosomes for the development of brain drug delivery systems[J].Bioconjug Chem,2019,30(4):994-1005.
27 Altaner C,Altanerova U.Mesenchymal stem cell exosome-mediated prodrug gene therapy for cancer[J].Methods Mol Biol,2019,1895:75-85.
28 Mughees M,Kumar K,Wajid S.Exosome vesicle as a nano-therapeutic carrier for breast cancer[J].J Drug Target,2021,29(2):121-130.
29 Fuhrmann G,Serio A,Mazo M,et al.Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins[J].J Control Release,2015,205:35-44.
30 Wu Q,Zhou L,Lv D,et al.Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression[J].J Hematol Oncol,2019,12(1):53.
31 Jena BC,Das CK,Bharadwaj D,et al.Cancer associated fibroblast mediated chemoresistance:A paradigm shift in understanding the mechanism of tumor progression[J].Biochim Biophys Acta Rev Cancer,2020,1874(2):188416.
32 Cheng L,Sharples RA,Scicluna BJ,et al.Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood[J].J Extracell Vesicles,2014,3(1):1-14.

[1]	WU Fangfang, ZHENG Tongsen. Research status and prospect of adjuvant therapy for biliary tract malignant tumors [J]. Journal of Practical Oncology, 2022, 36(2): 156-161.
[2]	SUN Yuanyuan, ZHANG Ningzhi, CAO Mengru. The mechanism and treatment progress of breast cancer lung metastasis [J]. Journal of Practical Oncology, 2022, 36(2): 173-177.
[3]	CHEN He, WANG Qiucheng, CHENG Wen. The application progress of automatic breast ultrasound diagnosis system in breast cancer [J]. Journal of Practical Oncology, 2022, 36(2): 193-196.
[4]	LI Weihua, ZHANG Guangfeng, MA Lili, HE Pin, WANG Wen, LI Dingfu. Construction of a breast cancer prognostic model based on metabolism-related genes in the TCGA database [J]. Journal of Practical Oncology, 2022, 36(1): 37-43.
[5]	CAO Shiyu, JIANG Yongdong. The influence of gene expression,polygene detection and biomarkers on the prognosis of Luminal A-like breast cancer [J]. Journal of Practical Oncology, 2022, 36(1): 89-93.
[6]	LUO Bo, ZHANG Qu, ZHENG Hongmei, LIANG Xinjun, ZHOU Xiaomei, WU Xinhong. Efficacy and prognosis of SRT combined with lapatinib in the treatment of HER2-positive breast cancer brain metastasis [J]. Journal of Practical Oncology, 2021, 35(6): 523-528.
[7]	SHI Runze, LI Zhigao. Research progress of precision medical strategy for different subtypes of triple negative breast cancer [J]. Journal of Practical Oncology, 2021, 35(6): 529-533.
[8]	LI Xiang, HU Yang, ZHANG Qingyuan. Research progress of tumor mutational burden as an emerging biomarker for breast cancer immunotherapy [J]. Journal of Practical Oncology, 2021, 35(6): 568-571.
[9]	ZHOU Tianhong, GU Xiuying, YAO Fang, SONG Shuming. Analysis for screening results of breast cancer in Urumqi from 2014 to 2018 [J]. Journal of Practical Oncology, 2021, 35(5): 391-395.
[10]	MA Buhuan¹, LIU Caixia². Research progress of Jagged1 promoting the occurrence,development and distant metastasis of breast cancer [J]. Journal of Practical Oncology, 2021, 35(5): 452-457.
[11]	QIN Chao, LI Jiang, ZHENG Yadi, WANG Fei, CAO Wei, XU Yongjie, YU Yiwen, ZHAO Liang, YU Xinyang, CHEN Hongda, REN Jiansong, WANG Yong, LI Jing, LI Ni, CHEN Wanqing. Analysis of screening compliance and related factors in high-risk populations of breast cancer in Chinese cities [J]. Journal of Practical Oncology, 2021, 35(4): 291-296.
[12]	GUO Lanwei, ZHANG Shaokai, LIU Shuzheng, ZHENG Liyang, CHEN Qiong, CAO Xiaoqin, SUN Xibin, ZHANG Jiangong. Analysis of compliance with breast cancer screening and its influencing factors in urban areas of Henan province [J]. Journal of Practical Oncology, 2021, 35(4): 307-313.
[13]	LI Yuying, ZHANG Yue. Research progress of Sirtuins in breast cancer [J]. Journal of Practical Oncology, 2021, 35(3): 277-281.
[14]	TI Qian, ZHANG Qingyuan. Research progress of CDK4/6 inhibitors combined with endocrine therapy for advanced breast cancer [J]. Journal of Practical Oncology, 2021, 35(3): 287-290.
[15]	YANG Min, ZHANG Jiaoyan, Duan Dan, XU Binghe. Bibliometrics and visual analysis of breast cancer caregivers [J]. Journal of Practical Oncology, 2021, 35(2): 110-116.

Research progress on the influence of exosomes in the integration of breast cancer diagnosis and treatment

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments